Affiliation: University of California
- Virus-host interactions in HIV pathogenesis: directions for therapyJ A Levy
Director, Laboratory for Tumor and AIDS Virus Research, University of California, San Francisco, San Francisco, CA 94143 1270, USA
Adv Dent Res 23:13-8. 2011..All these parameters in HIV pathogenesis underline the information needed to develop optimal anti-HIV therapies and an effective AIDS vaccine...
- Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral loadSteven G Deeks
San Francisco General Hospital, 995 Potrero Ave, San Francisco, CA 94110, USA
Blood 104:942-7. 2004..These data indicate that immunologic activation set point is established early in HIV infection, and that this set point determines the rate at which CD4+ T cells are lost over time...
- Natural suppression of human immunodeficiency virus type 1 replication is mediated by transitional memory CD8+ T cellsM Scott Killian
Department of Medicine, University of California San Francisco, San Francisco, California 94143 1270, USA
J Virol 85:1696-705. 2011..The findings better describe the identity of CD8(+) cells showing CNAR and should facilitate the evaluation of this important immune response in studies of HIV pathogenesis, resistance to infection, and vaccine development...
- Role of Innate Immunity in Controlling HIV InfectionJay A Levy; Fiscal Year: 2010..The identification of CAF has outstanding potential as a therapeutic agent for HIV infection and for the development of an effective vaccine. ..
- Role of Innate Immunity in Controlling HIV InfectionJay Levy; Fiscal Year: 2007..Finally, the clinical relevance of the identified CAF protein(s) to CNAR/CAF will be established by shRNA studies. ..
- Role of Innate Immunity in Controlling HIV InfectionJay Levy; Fiscal Year: 2006..Monoclonal antibodies will also be derived to establish a CAF specific ELISA and to use for flow cytometric studies in developing a diagnostic test to measure disease progression. ..
- Role of Innate Immunity in Controlling HIV InfectionJay Levy; Fiscal Year: 2009..The identification of CAF has outstanding potential as a therapeutic agent for HIV infection and for the development of an effective vaccine. ..